Gaudium IVF Faces Arbitration Over IPO Advisory Dispute

Gaudium IVF and Women Health Ltd has confirmed that the Bombay High Court has appointed Hon'ble Mr. Justice Nitin Jamdar as the Sole Arbitrator to resolve a dispute concerning IPO advisory services. The company stated this development has no immediate financial impact.

Neomile's ₹29.2 Crore Claim

The arbitration stems from a ₹29.2 crore claim from Neomile Corporate Advisory Limited over alleged IPO advisory services. Gaudium IVF has contested this demand, calling it unsubstantiated.

Court Appoints Sole Arbitrator

The Bombay High Court has formally disposed of a petition filed by Neomile Corporate Advisory Limited. In its ruling, the court appointed Hon'ble Mr. Justice Nitin Jamdar to serve as the Sole Arbitrator, tasked with resolving the contractual disagreement between the two parties.

Why This Arbitration Matters

This court-ordered arbitration establishes a formal process for settling the dispute, moving it away from broader litigation. While Gaudium IVF stated there are no current financial implications, the arbitration's outcome will ultimately determine the validity of Neomile's claim and any potential financial obligations for Gaudium IVF.

Financial Snapshot

Gaudium IVF's financial position as of September 30, 2025, shows total borrowings of ₹22.51 crore. The company also reported significant contingent liabilities amounting to ₹44.99 crore, representing approximately 76.4% of its net worth.

Broader Risks and Governance

Beyond this specific dispute, Gaudium IVF faces potential financial risks from ongoing tax litigation and significant contingent liabilities. Past legal issues, including an FIR filed against its founder, have also raised governance concerns.

Competitive Landscape

Operating in India's growing IVF market, Gaudium IVF competes with established players such as Indira IVF, Nova IVF Fertility, Apollo Fertility, and Max Healthcare, all catering to increasing demand for fertility treatments.

What to Track Next

Key developments to monitor include updates from the arbitration proceedings overseen by Mr. Justice Nitin Jamdar. Investors will also look for any further disclosures from Gaudium IVF regarding the arbitration's progress or potential financial outcomes, alongside continued attention to the company's other legal and tax matters.